Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Puiggros, Anna|||0000-0001-9627-4978
  • Baliakas, Panagiotis|||0000-0002-5634-7156
  • Athanasiadou, Anastasia
  • García-Malo, MaDolores
  • Collado, Rosa|||0000-0002-8205-6192
  • Xochelli, Aliki
  • Rodríguez-Rivera, María
  • Ortega, Margarita
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Luño, Elisa
  • Vargas, MªTeresa
  • Grau Cat, Javier
  • Martínez-Laperche, Carolina
  • Valiente, Alberto
  • Cervera, José|||0000-0001-8252-1106
  • Anagnostopoulos, Achilles|||0000-0003-4384-9031
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Stalika, Evangelia
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Robles, Diego
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Ivars, David
  • González, Marcos
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Stamatopoulos, Kostas|||0000-0001-8529-640X
  • Espinet Solà, Blanca|||0000-0002-4294-8145
Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53 abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53 abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, ≥3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10-year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53 abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

  • Puiggros, Anna|||0000-0001-9627-4978
  • Collado, Rosa|||0000-0002-8205-6192
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Ortega, Margarita
  • Ruiz-Xivillé, Neus
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Luño, Elisa
  • González, Teresa
  • Navarro, Blanca
  • García-Malo, MaDolores
  • Valiente, Alberto
  • Hernández, José Ángel
  • Ardanaz, María Teresa
  • Piñan, María Ángeles
  • Blanco, María Laura
  • Hernández-Sánchez, María|||0000-0001-9968-2782
  • Batlle Lopez, Ana|||0000-0003-4143-9020
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Salido, Marta|||0000-0001-9988-5977
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Terol, María José
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Costa, Dolors|||0000-0002-8276-3292
  • Moreno, Carol|||0000-0003-3275-0271
  • Carbonell, Félix
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Delgado, Julio|||0000-0002-5157-4376
  • Espinet i Solà, Blanca
Genomic complexity identified by chromosome banding analysis (CBA) predicts a worse clinical outcome in CLL patients treated either with standard or new treatments. Herein, we analyzed the clinical impact of complex karyotypes (CK) with or without high-risk FISH deletions (ATM and/or TP53, HR-FISH) in a cohort of 1045 untreated MBL/CLL patients. In all, 99/1045 (9.5%) patients displayed a CK. Despite ATM and TP53 deletions were more common in CK (25% vs 7%; P < 0.001; 40% vs 5%; P < 0.001, respectively), only 44% (40/90) patients with TP53 deletions showed a CK. CK group showed a significant higher two-year cumulative incidence of treatment (48% vs 20%; P < 0.001), as well as a shorter overall survival (OS) (79 mo vs not reached; P < 0.001). When patients were categorized regarding CK and HR-FISH, those with both characteristics showed the worst median OS (52 mo) being clearly distinct from those non-CK and non-HR-FISH (median not reached), but no significant differences were detected between cases with only CK or HR-FISH. Both CK and TP53 deletion remained statistically significant in the multivariate analysis for OS. In conclusion, CK group is globally associated with advanced disease and poor prognostic markers. Further investigation in larger cohorts with CK lacking HR-FISH is needed to elucidate which mechanisms underlie the poor outcome of this subgroup.